Short Interest in BIO-key International Inc. (NASDAQ:BKYI) Declines By 29.4%

BIO-key International Inc. (NASDAQ:BKYI) was the target of a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 158,340 shares, a decline of 29.4% from the February 26th total of 224,434 shares. Based on an average trading volume of 583,713 shares, the short-interest ratio is presently 0.3 days. Currently, 1.5% of the company’s shares are short sold.

Institutional Investors Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC raised its stake in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 26.51% of the stock is owned by hedge funds and other institutional investors.

BIO-key International Stock Down 1.4%

BIO-key International stock opened at $0.57 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. The firm has a market cap of $6.22 million, a P/E ratio of -0.55 and a beta of 0.41. The business has a fifty day moving average of $0.63 and a two-hundred day moving average of $0.70. BIO-key International has a twelve month low of $0.51 and a twelve month high of $1.97.

Analysts Set New Price Targets

Several research firms have recently issued reports on BKYI. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, January 21st. Wall Street Zen raised shares of BIO-key International to a “sell” rating in a research report on Saturday, January 3rd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, BIO-key International has an average rating of “Sell”.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.